John Doe, PharmD, BCACP
Senior Writer
Specialties
Articles by John Doe
How to Switch from Ozempic to Wegovy: A Patient Guide
Both Ozempic and Wegovy are semaglutide, but FDA-approved for different conditions. Here is exactly how to switch — clinically, administratively, and practically.
Wegovy Cost Without Insurance: A 2026 Guide
Wegovy retails near $1,349/month without insurance. But several legitimate channels reduce the cost to $200-400/month. Here is a complete breakdown of your options in 2026.
Compounded Semaglutide in 2026: What the FDA Crackdown Means for You
In March 2026, the FDA sent warning letters to dozens of telehealth providers marketing compounded GLP-1 medications. This explainer covers what changed, why, and what your options are now.
Ozempic Face: Causes, Prevention, and How to Manage
"Ozempic face" refers to facial volume loss seen in some patients during GLP-1 weight loss. It is not a side effect of the drug itself, but a consequence of rapid fat loss. Here is what to know.
GLP-1 Weight Loss Timeline: Realistic Results Month by Month
Clinical trial data shows where you are likely to be at each stage of GLP-1 weight loss treatment. Here is a month-by-month timeline of realistic expectations.